載入...

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

There is an unmet medical need for anabolic treatments to restore lost bone. Human genetic bone disorders provide insight into bone regulatory processes. Sclerosteosis is a disease typified by high bone mass due to the loss of SOST expression. Sclerostin, the SOST gene protein product, competed with...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Winkler, David G., Sutherland, May Kung, Geoghegan, James C., Yu, Changpu, Hayes, Trenton, Skonier, John E., Shpektor, Diana, Jonas, Mechtild, Kovacevich, Brian R., Staehling-Hampton, Karen, Appleby, Mark, Brunkow, Mary E., Latham, John A.
格式: Artigo
語言:Inglês
出版: Oxford University Press 2003
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC291840/
https://ncbi.nlm.nih.gov/pubmed/14633986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/emboj/cdg599
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!